Loading clinical trials...
Loading clinical trials...
Muscular dystrophies are neurologic disease with higher morbidity and mortality. Cardiac function and respiratory muscles can be affected, in addition with skeletal muscle deficiency . Lung function is classically assessed with functionnal pulmonary tests (FPT) . Ultrasound recently emerged as a non-invasive tool to assess diaphragm function. The aims of the study are: * to provide the spectrum of diaphragm ultrasound in patients with muscular dystrophies * to assess the correlation between diaphragm ultrasound and FPT * to assess the correlation between diaphragm ultrasound and cardiac function
Age
All ages
Sex
ALL
Healthy Volunteers
No
Hopital Raymond Poincare
Garches, France
Start Date
May 15, 2019
Primary Completion Date
December 28, 2019
Completion Date
May 10, 2020
Last Updated
August 5, 2019
1,000
ESTIMATED participants
Lead Sponsor
Centre d'Investigation Clinique et Technologique 805
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions